Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
7,975,977
-
Share change
-
+990,568
-
Total reported value
-
$54,954,034
-
Put/Call ratio
-
16%
-
Price per share
-
$6.89
-
Number of holders
-
31
-
Value change
-
+$6,891,184
-
Number of buys
-
10
-
Number of sells
-
11
Institutional Holders of MERRIMACK PHARMACEUTICALS IN - COM NEW (MACK) as of Q4 2020
As of 31 Dec 2020,
MERRIMACK PHARMACEUTICALS IN - COM NEW (MACK) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,975,977 shares.
The largest 10 holders included
Newtyn Management, LLC, 22NW, LP, Western Standard LLC, Nantahala Capital Management, LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, Bronte Capital Management Pty Ltd., TWO SIGMA INVESTMENTS, LP, BlackRock Inc., and TWO SIGMA ADVISERS, LP.
This page lists
31
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.